Business Context and Reporting Period
Company: Oaktree Specialty Lending Corporation (OCSL)
Filing Type: Form 8-K (Current Report)
Date of Report: February 8, 2023
Reporting Period: Event date of February 8, 2023
The filing reports the entry into a material definitive agreement regarding the Company's equity distribution capabilities.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document is a legal disclosure regarding a corporate agreement.
Material Changes
On February 8, 2023, the Company entered into an amendment to its Equity Distribution Agreement dated February 7, 2022. Key changes include:
- Continuation of Sales: The amendment allows for the sale of shares pursuant to the Equity Distribution Agreement to continue under the Company's currently effective shelf registration statement (Form N-2, Registration No. 333-269628).
- Parties Involved: The agreement involves Oaktree Specialty Lending Corporation, Oaktree Fund Advisors, LLC, Oaktree Fund Administration, LLC, and placement agents Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc., and SMBC Nikko Securities America, Inc.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the report does not constitute an offer to sell or a solicitation of an offer to buy securities. Sales are subject to state securities laws and registration requirements.
Legal Opinion: Kirkland & Ellis LLP delivered a legality opinion regarding the shares of common stock to be sold under the agreement.
Risks and Contingencies: The filing notes that no sale of securities will occur in any jurisdiction where such an offer or sale would be unlawful prior to registration or qualification.
Investor Verification Checklist
- Verify the full text of the Amendment to the Equity Distribution Agreement (Exhibit 1.1) for specific terms not detailed in the summary.
- Confirm the status of the shelf registration statement (Form N-2, No. 333-269628) to ensure it remains effective for future sales.
- Review the legality opinion from Kirkland & Ellis LLP (Exhibit 5.1) for any conditions attached to the share issuance.
- Monitor subsequent filings for actual sales volumes and proceeds generated under the amended agreement.